According to the Zhitong Finance App, Sihuan Pharmaceutical (00460.HK) announced that recently, the injectable polycaprolactone microsphere facial filler (PCL) and injectable sodium hyaluronate complex solution (FL) (kinetics)) independently developed and produced by the group's subsidiary, have been approved for listing in the Hong Kong Special Administrative Region of China. The approved specifications for injectable polycaprolactone microsphere facial fillers include 0.5mL/stick, 1.0mL/ stick; the approved specifications for the injectable sodium hyaluronate compound solution include 0.5mL/stick, 1.0mL/stick, 1.5mL/stick, 2.0mL/stick, 2.5mL/stick, 3.0mL/stick, 5mL/box (containing 2 2.5mL/stick).

According to the Zhitong Finance App, Sihuan Pharmaceutical (00460.HK) announced that recently, the injectable polycaprolactone microsphere facial filler (PCL) and injectable sodium hyaluronate complex solution (FL) (kinetics)) independently developed and produced by the group's subsidiary, have been approved for listing in the Hong Kong Special Administrative Region of China. The approved specifications for injectable polycaprolactone microsphere facial fillers include 0.5mL/stick, 1.0mL/ stick; the approved specifications for the injectable sodium hyaluronate compound solution include 0.5mL/stick, 1.0mL/stick, 1.5mL/stick, 2.0mL/stick, 2.5mL/stick, 3.0mL/stick, 5mL/box (containing 2 2.5mL/stick).